Search filters

List of works by Francesca Gay

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease

scientific article published on 22 October 2015

A new combination for advanced multiple myeloma

scientific article published on 21 February 2011

An European Myeloma Network recommendation on tools for diagnosis and monitoring of multiple myeloma: what to use and when

scholarly article by Jo Caers et al published 31 August 2018 in Haematologica

Autologous Transplantation in Elderly Multiple Myeloma Patients: Is the Procedure Cost Effective?

scientific article published on 8 August 2015

Autologous transplant for myeloma: when the old meets the new.

scientific article published on 8 October 2017

Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis.

scientific article published on 23 December 2016

Autologous transplantation and maintenance therapy in multiple myeloma

scientific article published on September 2014

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results.

scientific article published on 17 June 2013

Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma.

scientific article

CD38 As an Immunotherapeutic Target in Multiple Myeloma

scientific article published on 13 November 2018

Cardiovascular adverse events in modern myeloma therapy - incidence and risks. A review from European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)

article

Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial

scientific article

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies

scientific article

Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma

scientific article

Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma.

scientific article

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents

scientific article published on 14 April 2020

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

scientific article published on 12 January 2011

Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma.

scientific article

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials

scientific article published on 14 September 2018

Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma.

scientific article

CyTOF®: A New Tool to Decipher the Immunomodulatory Activity of Daratumumab

scientific article published on 25 March 2019

Do we need cytogenetics in the follow-up of multiple myeloma?

scientific article published on 01 February 2019

Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma.

scientific article published on 25 August 2011

Efficacy and safety of bortezomib in patients with plasma cell leukemia

scientific article published on 01 June 2007

Emerging drugs and combinations to treat multiple myeloma

scientific article published on 15 July 2017

Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study

scientific article published on 31 March 2019

European Myeloma Network guidelines for the management of multiple myeloma-related complications

scientific article

European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma

scientific article published on February 2014

European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias

scientific article published on 23 July 2018

Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy

scientific article published on 26 March 2018

Evaluation of the pharmacokinetics, preclinical, and clinical efficacy of lenalidomide for the treatment of multiple myeloma

scientific article published on 03 August 2012

From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

scientific article

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib

scientific article published on February 2014

How to treat elderly patients with multiple myeloma: combination of therapy or sequencing.

scientific article published on January 2009

Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).

scientific article published on 16 October 2015

Immuno-oncologic Approaches: CAR-T Cells and Checkpoint Inhibitors

scientific article

Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?

scientific article published on 27 December 2017

Insights into defibrotide: an updated review.

scientific article published on June 2009

Intermediate-dose melphalan (100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma

scientific article published on 01 May 2006

Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

scientific article published on 21 December 2017

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

scientific article

Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials.

scientific article published on 22 December 2016

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

scientific article

Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma

scientific article

Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients

scientific article published on 21 September 2012

Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects.

scientific article published on 16 April 2009

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients

scientific article published on 23 January 2014

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis

scientific article published on 01 October 2018

Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis

scientific article published on 19 April 2018

Management of disease- and treatment-related complications in patients with multiple myeloma.

scientific article published in June 2010

Management of myeloma: an Italian perspective

scientific article published on 12 May 2011

Management of older patients with multiple myeloma.

scientific article published on 04 February 2011

Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

scientific article published on 22 May 2020

Melphalan and its role in the management of patients with multiple myeloma.

scientific article published on July 2007

Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial

scientific article

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis.

scientific article published on 13 October 2016

Monoclonal antibodies currently in Phase II and III trials for multiple myeloma.

scientific article published on 21 April 2014

Novel investigational drugs active as single agents in multiple myeloma.

scientific article

Nuances in the Management of Older People With Multiple Myeloma

scientific article published on 2 April 2016

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.

scientific article published on 27 May 2008

Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN)

Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma.

scientific article published on 21 August 2013

Plasma cell leukemia: update on biology and therapy.

scientific article published on 6 November 2016

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network.

scientific article published on 2 May 2018

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension

scientific article published on 08 April 2019

Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients

scientific article published on 18 February 2011

Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma

scientific article published on 27 November 2018

Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies

scientific article published on 13 December 2019

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

scientific article published on 19 August 2020

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

scientific article published on 3 August 2015

Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma.

scientific article published on 28 November 2016

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

scientific article published in 2022

Special problems in the management of elderly patients with multiple myeloma

scientific article published on 01 December 2018

Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma

scientific article published on 05 November 2020

Stem Cell Transplantation in Multiple Myeloma.

scientific article published on 19 September 2016

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network

scientific article

The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens

scientific article published on 18 November 2010

The role of pre-transplant induction regimens and autologous stem cell transplantation in the era of novel targeted agents

scientific article published on March 2015

Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.

scientific article

Towards a new standard of care for patients with myeloma?

scientific article published on 21 October 2009

Treatment of Newly Diagnosed Elderly Multiple Myeloma.

scientific article published on January 2016

Trichoderma species fungemia after high-dose chemotherapy and autologous stem cell transplantation: a case report

scientific article published on 11 June 2014

Paulina is supported by:

About Paulina

Help